Found 49 matching trials
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes PHASE2 A multicenter, randomized, double-blind, placebo-controlled, group-comparis...
Show More Location
Multiple Locations
Learn More & Join Trial
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
Incretin Effect on the Immunological Phenotype PHASE2 Assessment of the effect of incretin based therapies (Liraglutide and Saxag...
Show More Location
Medical University Graz
Learn More & Join Trial
24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy PHASE4 SMART Study - A 24-Week, Multicenter, Randomized, Parallel-group, Open-labe...
Show More Learn More & Join Trial
A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration PHASE1 The primary objective of this study is to assess the pharmacokinetic parame...
Show More Learn More & Join Trial
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control PHASE3 Saxagliptin is a new investigational medication being developed for treatme...
Show More Learn More & Join Trial
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy PHASE4 Study Hypothesis:Compared with premixed insulin, triple oral combination th...
Show More Location
The Pearl River Hospital of Southern Medical University
Learn More & Join Trial
Neuropeptide Y and Sympathovagal Balance EARLY_PHASE1 Neuropeptide Y (NPY) activates the sympathetic and vagal nervous systems th...
Show More Location
Service de Néphrologie
Learn More & Join Trial
Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes PHASE4 The intestinal microflora imbalance has been associated with obesity and ty...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity PHASE4 The purpose of the study is to examine the effect of Saxagliptin in the new...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial